Deeptech bioeconomy – The battle for green solutions

Faster, bolder, simpler – Ursula von der Leyen’s cabinet is charting a course with January’s Clean Industrial Deal. However, struggles between Commissioners over responsibilities and a lack of strategic investment in the EU bioeconomy to reduce CAPEX costs for green plants to produce fossil-free sustainable aviation fuels, chemicals, cultivated food, feed, ingredients and compostable materials that can replace plastics are currently jeopardising one of Europe’s biggest economic opportunities for a recovery – and for growing less dependent on China and the US.

In this issue:

• The crossroads of the next pandemic – What do global pandemics and the growing crisis of antimicrobial resistance have in common?
• Interview with Henry Skinner, CEO AMR Action Fund
• Polish EU Council Presidency: Rapid agreement on EU NGT Regulation in sight
• Interview: Alessandro Toniolo, CEO at Resalis Tx, on the first obesity anti-sense trial and the Sanofi deal
• Update of ongoing clinical trials, News from the Stock markets,
• BioMed X launches new institute
• European Medicines Agency reports record number of new drug authorisations
• Foodtech industry disappointed over EU-Vision for Food and Agriculture
• Focus lab Automation: Technology and system integration, Interview: Enrico Grassilli, CEO, InSimili srl, Bologna, Novel sequencing technology
• Aspirin triggers metastasis resistance
• UK biobank data analysed for disease prediction
• Regional news, news from BIOTECH Austria, Society for Laboratory Automation and Screening (SLAS) and the Young European Biotech Network
• SPECIAL: Oligonucleotides and Peptides